Top 10 expensive drugs in Canada by annual cost per beneficiary 2016/17

Top 10 most expensive drugs in Canadian public drug plans in FY 2016/2017, by average annual cost per beneficiary (in Canadian dollars)*

by Matej Mikulic, last edited Oct 16, 2018
Top 10 expensive drugs in Canada by annual cost per beneficiary 2016/17 This statistic depicts the top 10 most expensive drugs in Canadian public drug plans in FY 2016/2017, by average annual cost per beneficiary, in Canadian dollars. Myozyme (alglucosidase alfa) was the most expensive drug in Canada with an average annual cost of nearly 600 thousand Canadian dollars per beneficiary.
Show more

Top 10 most expensive drugs in Canadian public drug plans in FY 2016/2017, by average annual cost per beneficiary (in Canadian dollars)*

Loading statistic...
Trade name (ingredient)Annual cost per beneficiary in Canadian dollars
Myozyme (alglucosidase alfa)596,513
Soliris (eculizumab)433,796
VPRIV (velaglucerase alfa)360,203
Kalydeco (ivacaftor)255,608
Remodulin (treprostinil)124,874
Zavesca (miglustat)113,445
Prolastin C (alpha 1-proteinase inhibitor)104,213
Pheburane (sodium phenylbutyrate)76,178
Somavert (pegvisomant)70,594
Sovaldi (sofosbuvir)68,716
Trade name (ingredient)Annual cost per beneficiary in Canadian dollars
Myozyme (alglucosidase alfa)596,513
Soliris (eculizumab)433,796
VPRIV (velaglucerase alfa)360,203
Kalydeco (ivacaftor)255,608
Remodulin (treprostinil)124,874
Zavesca (miglustat)113,445
Prolastin C (alpha 1-proteinase inhibitor)104,213
Pheburane (sodium phenylbutyrate)76,178
Somavert (pegvisomant)70,594
Sovaldi (sofosbuvir)68,716
Download Settings Share
Download started
Please be patient - this may take a moment
by Matej Mikulic, last edited Oct 16, 2018
This statistic depicts the top 10 most expensive drugs in Canadian public drug plans in FY 2016/2017, by average annual cost per beneficiary, in Canadian dollars. Myozyme (alglucosidase alfa) was the most expensive drug in Canada with an average annual cost of nearly 600 thousand Canadian dollars per beneficiary.
Show more
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.